Delivery Order SPE2DB20D1100-SPE2DB25FC7R1
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $11,136.91 for Xulane 150-35 mcg/day contraceptive patches (3-count units) on July 2, 2025, with an ultimate completion date of July 3, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $12,138.34 to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day contraceptive patches (3-count units). This firm fixed-price, competitively awarded delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a $2,206.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count supply) on August 21, 2025, with completion scheduled for August 22, 2025. This non-competitive delivery order was issued from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,428.13 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-pack units). This competitively awarded, non-set-aside delivery order reflects firm fixed pricing and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,082.94 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-pack units) on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,033.23 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-count units). This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The work will be performed at the vendor's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,670.35 on August 25, 2025, for Xulane 150-35 mcg/day contraceptive patches (quantity of 3 units). This firm fixed-price delivery order, which is not set-aside, is expected to be completed by August 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $3,988.76 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count). This firm fixed-price, competitively awarded contract was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,497.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (quantity: 3) on September 19, 2025, with completion targeted for September 22, 2025. This non-set-aside award was made competitively and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $10,483.60 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count supply). The contract, awarded on May 23, 2025, with an ultimate completion date of May 27, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC7R1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,490.30 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count). This firm fixed price, non-set-aside contract was awarded on June 6, 2025, with an ultimate completion date of June 9, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company's federal procurement portfolio demonstrates consistent capability in competitively awarded contracts across multiple therapeutic domains, positioning it as a key vendor for specialized pharmaceutical commodities required by the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 6/6/25 |